Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer

BACKGROUND: The consequences of low prostate-specific antigen (PSA) in high-grade (Gleason 8–10) prostate cancer are unknown. OBJECTIVE: To evaluate the clinical implications and genomic features of low-PSA, high-grade disease. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective study of cli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur Urol
Hauptverfasser: Mahal, Brandon A., Yang, David D., Wang, Natalie Q., Alshalalfa, Mohammed, Davicioni, Elai, Choeurng, Voleak, Schaeffer, Edward M., Ross, Ashley E., Spratt, Daniel E., Den, Robert B., Martin, Neil E., Mouw, Kent W., Orio, Peter F., Choueiri, Toni K., Taplin, Mary-Ellen, Trinh, Quoc-Dien, Feng, Felix Y., Nguyen, Paul L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6615042/
https://ncbi.nlm.nih.gov/pubmed/29478736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2018.01.043
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge